Skip to main content
BTSG logo

BTSG · BrightSpring Health Services, Inc.

Track BTSG — free
$61.71 +1.48 (+2.46%) At close · Aug 14
Market Cap
$12.21B
Shares
197.86M

BrightSpring Health Services, Inc. Earnings Call Transcripts

Every quarterly earnings call for BrightSpring Health Services, Inc. (BTSG) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-07-31
BrightSpring Health Services, Inc. Second Quarter 2026 Earnings Call
Revenue
$3.87B
▲ 23% YoY
Diluted EPS
$0.38
▲ 192.3% YoY
Gross margin
12.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
William Blair 46th Annual Growth Stock Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-01
BrightSpring Health Services, Inc. Q1 FY2026 Earnings Call
Confident tone Pharmacy solutions growth Community living divestiture and balance sheet Investment and SG&A spend
Revenue
$3.61B
▲ 25.6% YoY
Diluted EPS
$0.67
▲ 378.6% YoY
Gross margin
13.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-27
BrightSpring Health Services, Inc. Q4 FY2025 Earnings Call
Confident tone Operational Efficiency and Margins 2026 Guidance IRA / LTC Headwind
Revenue
$3.55B*
▲ 91% YoY
Gross margin
11.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-28
BrightSpring Health Services, Inc. Q3 FY2025 Earnings Call
Confident tone 2025 Guidance Increase & Margin Expansion Specialty & Infusion Limited Distribution Drugs M&A: Amedisys, LHC, Community Living Divestiture
Revenue
$3.33B
▲ 14.7% YoY
Diluted EPS
$0.26
Gross margin
11.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-01
BrightSpring Health Services, Inc. Q2 FY2025 Earnings Call
Confident tone Specialty Pharmacy and LDD Growth Procurement and Cost Savings M&A Integration and Acquisitions
Revenue
$3.15B
▲ 15.3% YoY
Diluted EPS
$0.13
▲ 30% YoY
Gross margin
11.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-02
BrightSpring Health Services, Inc. Q1 FY2025 Earnings Call
Confident tone First quarter financial performance Home health and hospice quality Community living divestiture
Revenue
$2.88B
▲ 11.7% YoY
Diluted EPS
$0.14
Gross margin
11.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-06
BrightSpring Health Services, Inc. Q4 FY2024 Earnings Call
Confident tone Pharmacy segment margin and mix Revenue and EBITDA growth Community Living divestiture
Revenue
$1.86B*
▲ 50% YoY
Gross margin
18.2%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-01
BrightSpring Health Services, Inc. Q3 FY2024 Earnings Call
Confident tone Pharmacy segment growth Provider Services performance 2024 guidance raise
Revenue
$2.91B
▲ 28.8% YoY
Diluted EPS
$-0.04
Gross margin
11.1%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
BrightSpring Health Services, Inc. Q2 FY2024 Earnings Call
Confident tone Pharmacy Solutions Growth Provider Services Performance Raised 2024 Guidance
Revenue
$2.73B
▲ 26% YoY
Diluted EPS
$0.10
▲ 233.3% YoY
Gross margin
11.4%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
BrightSpring Health Services, Inc. Q1 FY2024 Earnings Call
Confident tone Pharmacy Solutions Growth Operational Initiatives and Quality Provider Services Performance
Revenue
$2.58B
▲ 27% YoY
Diluted EPS
$-0.26
Gross margin
11.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
BrightSpring Health Services, Inc. Q4 FY2023 Earnings Call
Confident tone Pharmacy Services Growth Financial Results & 2024 Guidance Integrated Care / Value-Based Care Strategy
Revenue
$1.24B*
Gross margin
6.0%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–13 of 13 earnings calls
Key facts CIK 1865782 CUSIP 10950A106 13F (30d) 414 filings 409 filers Visit website Investor relations